Extending Veteran Participation in the Validation of the SCI-QOL/CAT
扩大退伍军人参与 SCI-QOL/CAT 验证的范围
基本信息
- 批准号:8262130
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAmyotrophic Lateral SclerosisAwardBiological ModelsBostonCharacteristicsComputersContractsDisadvantagedDiseaseEpilepsyFoundationsFundingGeneral PopulationGoalsHealthHospitalsIndividualInformation SystemsInstitutesInstitutionInterventionMeasurementMeasuresMedicalMedical ResearchMedical centerMichiganMultiple SclerosisMyasthenia GravisNational Institute of Neurological Disorders and StrokeNeuromuscular DiseasesOutcomeOutcome MeasureParkinson DiseasePatient Outcomes AssessmentsPatient Self-ReportPatientsPersonsPhasePhysical MedicinePopulationPsychometricsQuality of lifeRehabilitation ResearchReportingResearch PersonnelSamplingServicesSiteSpinal cord injuryStrokeSurveysTestingUnited States National Institutes of HealthUniversitiesValidationValidity and ReliabilityVeteransdisabilityhealth related quality of lifeimproved functioninginnovationinstrumentnervous system disordersoundtool
项目摘要
DESCRIPTION (provided by applicant):
The National Institutes of Health (NIH) has developed the roadmap initiative project entitled "Patient Reported Outcomes Measurement Information System (PROMIS)", a quality of life health outcomes survey for the general population. In 2004, because it was determined that persons with neurological disorders have different needs and medical issues than the general population, the National Institute of Neurological Disorders and Stroke (NINDS) awarded a separate contract to Dr. David Cella at Northwestern University, to develop a patient reported outcomes/health-related quality of life instrument specific for persons with the neurological disorders (Neuro-QOL). These disorders included: stroke, Parkinson's disease (PD), neuromuscular disorders [myasthenia gravis and amyotrophic lateral sclerosis (ALS)], epilepsy, and multiple sclerosis (MS). Persons with SCI were intentionally not included in the Neuro-QOL due to funding limitations and potential other more specific needs. The scarcity of valid and useful SCI-specific measurement tools hinders the efforts of researchers who are investigating interventions for improved function and quality of life in persons with SCI. A multisite collaborative study is ongoing to develop and field- test a meaningful, relevant and psychometrically sound health-related quality of life scale for use in an SCI population. This collaborative study of the SCI-QOL was originally funded as two separate projects that have subsequently joined forces. National Institute of Neurological Diseases and Stroke (NINDS) awarded funding to Dr. Alan Jette from Boston University, Boston, MA and the National Institute of Disability Rehabilitation Research (NIDRR) funded Dr. David Tulsky at the University of Michigan, Ann Arbor, MI to develop an SCI-specific patient reported outcomes measure of health-related quality of life, namely the SCI-QOL. None of the three projects PROMIS, NEURO-QOL, and SCI-QOL have specifically targeted veterans. The goals of this project are to include veterans with SCI (representing about one-fourth of all persons with SCI in the USA) in the validation phase of the spinal cord injury health-related quality of life (SCI-QOL). [This instrument is being developed by Dr. David Tulsky (formerly at the Kessler Medical Research Foundation/Kessler Institute but who has recently moved to the University of Michigan) in conjunction with investigators from several SCI model system sites and psychometricians at Northwestern University.] In addition to including veterans in the validation sample, our study proposes to determine if quality of life differences exist between veterans and nonveterans with SCI and to determine the sensitivity of the SCI- QOL by adding it to existing, ongoing interventional studies. The Bronx and Tampa VAMCs are uniquely posed to perform the pre and post sensitivity component of the SCI- QOL because of the numerous ongoing interventional studies being conducted in veterans with SCI at both institutions. Our Specific Aims are: 1) To examine the psychometric characteristics (reliability and validity) of the SCI-QOL in a population of veterans with SCI; 2) To determine whether measurement differences exist on the SCI-QOL (using differential item functioning) between veterans and nonveterans with SCI; and 3) To test the sensitivity of the SCI-QOL measures within the context of existing interventional studies by comparing it with the legacy tool(s) being used. We are proposing to study 400 veterans with SCI; 200 at the James J. Peters VA Medical Center, Bronx, NY and 200 at the James A. Haley VA Hospital, Tampa, FL over 3 years.
描述(由申请人提供):
美国国立卫生研究院(NIH)开发了名为“患者报告结果测量信息系统(PROMIS)"的路线图倡议项目,这是一项针对普通人群的生活质量健康结果调查。2004年,由于确定神经系统疾病患者与普通人群有不同的需求和医疗问题,国家神经系统疾病和中风研究所(NINDS)与西北大学的大卫切拉博士签订了一份单独合同,以开发一种患者报告的结果/健康相关的生活质量工具,专门用于神经系统疾病患者(Neuro-QOL)。这些疾病包括:中风、帕金森病(PD)、神经肌肉疾病[重症肌无力和肌萎缩侧索硬化症(ALS)]、癫痫和多发性硬化症(MS)。由于资金限制和潜在的其他更具体的需求,SCI患者故意不包括在神经生活质量中。 有效和有用的SCI专用测量工具的缺乏阻碍了研究人员的努力,他们正在调查改善SCI患者功能和生活质量的干预措施。正在进行一项多中心合作研究,以开发和现场测试一种有意义的、相关的和心理测量学上合理的健康相关生活质量量表,用于SCI人群。这项SCI-QOL的合作研究最初是作为两个独立的项目资助的,后来又联合起来。美国国家神经疾病和卒中研究所(NINDS)资助了马萨诸塞州波士顿市波士顿大学的Alan Jette博士,美国国家残疾康复研究所(NIDRR)资助了密歇根大学安阿伯的大卫·图尔斯基博士,以开发一种SCI特定的患者报告的健康相关生活质量结局指标,即SCI-QOL。PROMIS、NEURO-QOL和SCI-QOL这三个项目都没有专门针对退伍军人。该项目的目标是将SCI退伍军人(约占美国SCI患者的四分之一)纳入脊髓损伤健康相关生活质量(SCI-QOL)的验证阶段。[This该仪器由大卫·图尔斯基博士(以前在凯斯勒医学研究基金会/凯斯勒研究所工作,但最近搬到了密歇根大学)与来自几个SCI模型系统站点的研究人员和西北大学的心理测量学家一起开发。除了在验证样本中包括退伍军人外,我们的研究还建议确定退伍军人和非退伍军人SCI患者之间是否存在生活质量差异,并通过将其添加到现有的正在进行的干预性研究中来确定SCI- QOL的敏感性。布朗克斯和坦帕的VAMC是唯一能够执行SCI- QOL的前后敏感性部分的,因为在这两个机构的SCI退伍军人中正在进行许多正在进行的干预性研究。 我们的具体目标是:1)检查心理测量特征(信度和效度)的SCI-QOL在人群中的SCI; 2)以确定是否存在测量差异的SCI-QOL(使用差异项目功能)之间的退伍军人和非退伍军人与SCI;和3)通过将SCI-QOL测量与传统工具进行比较,在现有干预性研究的背景下测试SCI-QOL测量的灵敏度市.我们我们计划研究400名脊髓损伤的退伍军人,其中200名在纽约州布朗克斯的詹姆斯J彼得斯退伍军人医疗中心,200名在詹姆斯A。佛罗里达州坦帕的Haley VA医院超过3年。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ann Michele Spungen其他文献
Ann Michele Spungen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ann Michele Spungen', 18)}}的其他基金
Use of a Powered Orthotic Exoskeleton to Promote Mobility Through Improved Squat, Knee Flexion and Loading of the Paretic Leg in Persons with Chronic Stroke
使用动力矫形外骨骼通过改善慢性中风患者的下蹲、膝关节屈曲和瘫痪腿的负重来促进活动能力
- 批准号:
10631850 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Use of a Powered Orthotic Exoskeleton to Promote Mobility Through Improved Squat, Knee Flexion and Loading of the Paretic Leg in Persons with Chronic Stroke
使用动力矫形外骨骼通过改善慢性中风患者的下蹲、膝关节屈曲和瘫痪腿的负重来促进活动能力
- 批准号:
10155112 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Use of a Powered Orthotic Exoskeleton to Promote Mobility Through Improved Squat, Knee Flexion and Loading of the Paretic Leg in Persons with Chronic Stroke
使用动力矫形外骨骼通过改善慢性中风患者的下蹲、膝关节屈曲和瘫痪腿的负重来促进活动能力
- 批准号:
10012568 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Extending Veteran Participation in the Validation of the SCI-QOL/CAT
扩大退伍军人参与 SCI-QOL/CAT 验证的范围
- 批准号:
8088415 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Extending Veteran Participation in the Validation of the SCI-QOL/CAT
扩大退伍军人参与 SCI-QOL/CAT 验证的范围
- 批准号:
8928089 - 财政年份:2011
- 资助金额:
-- - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fellowship
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants














{{item.name}}会员




